Disclosure of shareholdings – Holta Invest AS (2025)

03. Mar 2025 | 1 min read

3 March 2025

Holta Invest AS has today sold 1,228,502 shares in Gentian Diagnostics ASA and holds after this transaction no longer any shares in Gentian Diagnostics ASA.

Consequently, Holta Invest AS has passed the 5% threshold pursuant to Section 4-2 (1) of the Norwegian Securities Trading Act.

This information is subject to the disclosure requirements pursuant to Section 4-2 and 5-12 of the Norwegian Securities Trading Act

You may also read


Nov 25, 2025 - Ole Sørlie

Gentian Diagnostics presents at the DNB Nordic Healthcare Conference

Moss, 25 November 2025 The CEO of Gentian Diagnostics, Mr. Matti Heinonen, will today give a company..

Nov 11, 2025 - Ole Sørlie

Financial calendar

Financial calendar for Gentian Diagnostics ASA